查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1357951

噬菌体治疗市场：依目标细菌、按适应症、按给药途径、按配销通路、按地区

Bacteriophage Therapy Market, By Targeted Bacteria, Disease Indication (Urinary Tract Infections, Chronic Otitis, Dental Extraction, Chronic Ulcerative Colitis, Bone Infection, & Other), Route of Administration, Distribution Channel & Geography
出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球噬菌体治疗市场预计到 2023 年将达到 12.809 亿美元，预计在预测期内（2023-2030 年）年复合成长率为 3.7%。

报告范围 报告详情
基准年 2022年 2023年市场规模 12.809 亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期年复合成长率 3.70% 2030年市场规模预测 16.518 亿美元
噬菌体疗法全球市场占有率(%)（依产品类型），2023 年
噬菌体治疗市场-IMG1

噬菌体，正式名称为噬菌体，是一种仅杀死并选择性靶向细菌的病毒。噬菌体是最常见的生物实体之一，可以有效对抗和消灭多重抗药性细菌。当所有抗生素都无法对抗感染疾病时，噬菌体可以杀死引起感染疾病的细菌，使医疗相关人员能够挽救生命。噬菌体被认为是抗生素的新治疗方法替代品。在这种治疗方法中，病毒将遗传物质注入细菌中，并利用宿主的机制自行繁殖。这种噬菌体疗法用于治疗或预防患者体内的细菌感染。噬菌体疗法在分子生物学和生物技术的研究领域也扮演着重要角色。这些要素正在扩大药物研发的可能性。

市场动态

内部成长策略的增加（例如法规产品核可以扩大主要参与者的市场组合）预计将在预测期内推动市场成长。例如，2021年9月，Adaptive Phage Therapeutics, Inc. (APT)，一家临床阶段的生物技术公司，提供专门治疗感染疾病的治疗方法，宣布获得额外的800万美元奖励，以继续开髮用于治疗感染疾病的噬菌体疗法（APT的PhageBankTM）。 Adaptive Phage Therapeutics, Inc. 很高兴 APT 的噬菌体库平台将帮助治疗多种适应症的抗药性感染疾病，并为我们国家的军事人员创造潜在的挽救生命的治疗方法。

本研究的主要特点

  • 该研究报告对全球噬菌体治疗市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030年）的市场规模和复合年度（年复合成长率）。
  • 它还阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场促进因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球噬菌体治疗市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、类型经营团队、市场扩张和行销策略做出资讯的决策。
  • 全球噬菌体治疗市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球噬菌体治疗市场的各种策略矩阵来促进决策。

目录

第1章调查目的和假设

  • 这项研究的目的
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第3章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 市场机会
  • 影响分析
  • 最近测试启动
  • 流行病学
  • 合併、收购和合作
  • 法规场景
  • 主要进展
  • PEST分析

第4章全球噬菌体治疗市场，COVID-19 的影响分析

  • 经济影响
  • 新型冠状病毒（COVID-19）的流行病学
  • 对需求和供给的影响

第5章全球噬菌体治疗市场，依目标细菌，2018-2030

  • 大肠桿菌
  • 金黄色葡萄球菌
  • 金黄色葡萄球菌
  • 链球菌
  • 铜绿假单胞菌
  • 沙门氏菌
  • 其他的

第6章全球噬菌体治疗市场，依适应症分类，2018-2030

  • 尿道感染
  • 慢性中耳炎
  • 拔牙
  • 慢性溃疡性大肠炎
  • 骨感染疾病
  • 伤口和皮肤感染疾病
  • 囊性纤维化
  • 其他的

第7章全球噬菌体治疗市场，依给药途径，2018-2030

  • 口服
  • 局部的
  • 胃肠外的

第8章全球噬菌体治疗市场（依配销通路），2018-2030

  • 医院药房
  • 零售药房
  • 网路药房

第9章全球噬菌体治疗市场，按地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争形势

  • 公司简介
    • Armata Pharmaceuticals, Inc.
    • Eliava Biopreparations Ltd
    • Pherecydes Pharma
    • Intralytix, Inc.
    • Phagelux, Inc.
    • Intralytix, Inc.
    • Nextbiotics
    • InnoPhage, Ltd
    • Locus Biosciences, Inc.
    • TechnoPhage
    • Eligo Bioscience SA
    • Phagomed Biopharma GmbH
    • PhagePro, Inc.
    • Adaptive Phage Therapeutics
    • Enbiotix, Inc
    • Intodeworld, Inc.
    • BiomX Ltd.
    • Phi Therapeutics
    • Fixed-phage Ltd
    • Micreos BV
    • ContraFect Corporation
    • OPTIPHARM Co., Ltd.

第11章章节

  • 参考
  • 调查方法
简介目录
Product Code: CMI2752

The global bacteriophage therapy market is estimated to be valued at US$ 1,280.9 million in 2023 and is expected to exhibit a CAGR of 3.7% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 1,280.9 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 3.70% 2030 Value Projection: US$ 1,651.8 Mn
Global Bacteriophage Therapy Market Share (%), By Product Type, 2023
Bacteriophage Therapy Market - IMG1

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are one of the most common biological entities that can effectively fight and destroy multi-drug-resistant bacteria. When all antibiotics fail to work against an infection, the phages are able to kill the bacteria causing the infection, thus helping medical professionals save life. Bacteriophages are being considered as a new alternative to antibiotics. In this therapy, the viruses are used to inject their genetic material into bacteria and use their host machinery to multiply themselves. This phage therapy is used to treat or prevent bacterial infections in patients' bodies. Bacteriophage therapy also plays a significant role in the research fields of molecular biology and biotechnology. These factors enhance the potential scope for drug discovery.

Market Dynamics

The increasing organic growth strategies, such as product approval by regulatory authorities to expand key players market portfolio, are expected to drive market growth over the forecast period. For instance, in September 2021, Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, announced that the Department of Defense (DoD), an executive branch department of the federal government of the U.S., had awarded the company an additional US$8 million for the continued development of bacteriophage therapies (APT's phage bankTM) for the treatment of infectious diseases. Adaptive Phage Therapeutics, Inc. said that it is thrilled APT's phage bank platform helps to treat drug-resistant infections across multiple indications that create potentially lifesaving therapies for the nation's service members.

Key features of the study:

  • This report provides an in-depth analysis of the global bacteriophage therapy market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global bacteriophage therapy market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Armata Pharmaceuticals, Inc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytix, Inc., Phagelux, Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc., TechnoPhage, Eligo Bioscience SA, Phagomed Biopharma GmbH., PhagePro, Inc., Adaptive Phage Therapeutics, Enbiotix, Inc., Intodeworld, Inc., BiomX Ltd., Phi Therapeutics, Fixed-phage Ltd., Micreos BV, ContraFect Corporation, OPTIPHARM Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global Bacteriophage Therapy Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacteriophage therapy market.

Detailed Segmentation:

  • Global Bacteriophage Therapy Market, By Targeted Bacteria:
    • Escherichia coli
    • Staphylococcus aureus
    • Streptococcus
    • Pseudomonas aeruginosa
    • Salmonella
    • Others
  • Global Bacteriophage Therapy Market, By Disease Indication:
    • Urinary Tract Infections
    • Chronic Otitis
    • Dental Extraction
    • Chronic Ulcerative Colitis
    • Bone Infection
    • Wound and Skin Infections
    • Cystic Fibrosis
    • Others
  • Global Bacteriophage Therapy Market, By Route of Administration:
    • Oral
    • Topical
    • Parenteral
  • Global Bacteriophage Therapy Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Bacteriophage Therapy Market, By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Armata Pharmaceuticals, Inc.
    • Eliava Biopreparations Ltd.
    • Pherecydes Pharma
    • Intralytix, Inc.
    • Phagelux, Inc.
    • Nextbiotics
    • InnoPhage, Ltd
    • Locus Biosciences, Inc.
    • TechnoPhage
    • Eligo Bioscience SA
    • Phagomed Biopharma GmbH.
    • PhagePro, Inc.
    • Adaptive Phage Therapeutics
    • Enbiotix, Inc.
    • Intodeworld, Inc.
    • BiomX Ltd.
    • Phi Therapeutics
    • Fixed-phage Ltd.
    • Micreos BV
    • ContraFect Corporation
    • OPTIPHARM Co., Ltd.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Targeted Bacteria
    • Market Snippet, By Disease Indication
    • Market Snippet, By Route of Administration
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Test Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Bacteriophage Therapy Market, - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Bacteriophage Therapy Market, By Targeted Bacteria, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Escherichia coli
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Staphylococcus aureus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Staphylococcus aureus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Streptococcus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Pseudomonas aeruginosa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Salmonella
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

6. Global Bacteriophage Therapy Market, By Disease Indication, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Urinary Tract Infections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Chronic Otitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Dental Extraction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Chronic Ulcerative Colitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Bone Infection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Wound and Skin Infections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Cystic Fibrosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

7. Global Bacteriophage Therapy Market, By Route of Administration, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Parenteral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

8. Global Bacteriophage Therapy Market, By Distribution Channel, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

9. Global Bacteriophage Therapy Market, By Region, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 -2030, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profiles
    • Armata Pharmaceuticals, Inc. *
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Eliava Biopreparations Ltd
    • Pherecydes Pharma
    • Intralytix, Inc.
    • Phagelux, Inc.
    • Intralytix, Inc.
    • Nextbiotics
    • InnoPhage, Ltd
    • Locus Biosciences, Inc.
    • TechnoPhage
    • Eligo Bioscience SA
    • Phagomed Biopharma GmbH
    • PhagePro, Inc.
    • Adaptive Phage Therapeutics
    • Enbiotix, Inc
    • Intodeworld, Inc.
    • BiomX Ltd.
    • Phi Therapeutics
    • Fixed-phage Ltd
    • Micreos BV
    • ContraFect Corporation
    • OPTIPHARM Co., Ltd.

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact